• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Infections - Bacterial Infections Drug Pipeline Report Product Image

Infections - Bacterial Infections Drug Pipeline Report

  • Published: June 2007
  • 22 pages
  • Life Science Analytics

Life Science Analytics, "Infections - Bacterial Infections Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of bacterial infections drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. READ MORE >

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Bacterial Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects



--Top Companies in late stage Bacterial Infections Projects
--Asubio Pharma Co., Ltd.
--Asahi Kasei Corporation
--Hi-Tech Pharmacal Co Inc
--DAIICHI SANKYO COMPANY, LIMITED
--Meiji Seika Kaisha, Ltd.
--Kyoto Pharmaceutical Industries
--Nippon Shinyaku Co., Ltd.
--Mylan, Inc.
--Ranbaxy Laboratories Ltd.
--Pfizer Inc
--Replidyne Inc
--RECORDATI SpA
--Roche Holdings Ltd
--Rib-X Pharmaceuticals, Inc.
--Star Laboratories
--Ltd.
--Schering-Plough Corp
--Teva Pharmaceutical Industries Ltd
--Taisho Pharmaceutical Co., Ltd.
--Yuhan Corporation
--TOYAMA CHEMICAL CO.,LTD.

--Top Companies in early stage Bacterial Infections Projects
--Affinium Pharmaceuticals, Inc.
--ADVENTRX Pharmaceuticals Inc
--Aphios Corporation
--Amura Holdings Ltd.
--Basilea Pharmaceutica AG
--Arpida Ltd.
--DAIICHI SANKYO COMPANY, LIMITED
--Cangene Corporation
--Forest Laboratories Inc
--Dainippon Sumitomo Pharma Co., Ltd.
--Grupo Ferrer
--GlaxoSmithKline plc
--Intercell AG
--Inimex Pharmaceuticals Inc.
--Paratek Pharmaceuticals, Inc
--Novexel
--Prolysis Limited
--Pfizer Inc
--Wyeth
--Vertex Pharmaceuticals Inc

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format.
Hard Copy A printed copy of the report will be shipped to you.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos